SIDP is excited to endorse the ACCP International Consensus Recommendations for the Use of Prolonged-Infusion β-Lactams! Review the guidance here: doi.org/10.1002/phar.2…

Pumpkin carving contest at work. I think our clinic rocked it!! #OPAT #Halloween2023

Great title -- really gets the message out there! doi.org/10.1093/cid/ci…

Thanks to @MsSmallsO for highlighting our OPAT study at ASHP Midyear. Taylor Epperson was the lead on this study looking at our OPAT program which showed reduced readmissions in patients discharged on vancomycin followed by a pharmacist in OPAT. pubmed.ncbi.nlm.nih.gov/36714295/

Go check out our amazing resident posters now until 3 pm! PGY2 ED Brianna Brown Pharm.D. is working on pharmacist-managed ED culture call back and Kacie Godwin is improving stewardship for urine cultures to decrease unnecessary treatment of ASB! FirstHealth #ASHP23

Regular doses of tragedy and still responsible for 3x your normal workload? That was my 2020. Just like most of #IDTwitter. Talking about it was surprisingly therapeutic. Thanks Paul Sax

More fuel to add to my anti-Cefdinir, pro-cephalexin for ecoli UTI fire 🔥 academic.oup.com/ofid/article/1…

Making the EHR work for you - Modifications of an Electronic Health Record System to Improve Tracking and Management of Patients Receiving Outpatient Parenteral Antibiotic Therapy ✅ Just Accepted 🔓 Open Access 🔗 bit.ly/3Stkzqg Sonal Munsiff

Lots of new data coming out in the ID space lately 🔥🔥🔥 check out some of the new articles ⬇️: SABATO 💉 vs. 💊: thelancet.com/journals/lanin… REGARD-VAP 🫁: thelancet.com/journals/lanre… #IDXPosts #IDTwitter

🔥PUBLISHED 🔥 The Lancet Infectious Diseases Global guideline for the diagnosis and management of cryptococcosis:an initiative of the ECMM & ISHAM in cooperation ASM 🌟s Dr. David B Martin Hoenigl🇺🇦🇦🇹 FungalDoc: moved to bluesky Oliver Cornely Ferry Hagen 🔬🧫🧬 thelancet.com/journals/lanin…

Nearly 2x as much treatment failure at 14 days when using cefdinir, compared to cephalexin which has substantially better bioavailability and urinary concentrations in lower UTIs. Makes sense! #downwithcefdinir

🆕️🔥The largest real-world, multicenter study of dalbavancin use for Gram-positive BSI Nicholas Rebold, PharmD, MPH, BCIDP, AAHIVP Michael Rybak and many SIDP 🌟s Dalbavancin Sequential Therapy for Gram-Positive Bloodstream Infection #IDXposts #DOTS link.springer.com/article/10.100…

💥CLSI M100 34rd Edition Updates 👇 - A thread 🧵 #MicroRounds #IDXPosts #IDTwitter (a bit late because I’m 🤒)

Must read! 📖 New SIDP & Contagion Bench to Bedside 🧪 🧫 👩‍⚕️ where Drs. Cara Nys Slaton and Mohamed Hisham Basheer discuss role of non-carbapenem therapy for infected necrotizing pancreatitis! Available here: buff.ly/48KzYXR

Definitely team daptomycin for OPAT. Unfortunately, sometimes the copays are still too high for our patients. Especially Medicare patients since Medicare doesn’t cover OPAT well.

Outpatient Parenteral Antimicrobial Therapy (OPAT) in a Safety-net Hospital: Opportunities for Improvement ✅ Just Accepted 🔓 Open Access 🔗 bit.ly/49EThTb

Congrats to our award winners at #SIDP2024! 🎉 Our Infectious Diseases Pharmacotherapy Paper Award Winner, Dr. Nikki Tran & team!

Happy antibiotic awareness week. Disclaimer: many viruses pictured, but remember antibiotics do not treat viruses! #USAAW24 #antibiotic

Is it time for global harmonization of opat drug stability testing frameworks? Great to collaborate with ⁦⁦Jason Roberts⁩ ⁦Fekade B Sime⁩ ⁦⁩ ⁦CRE RESPOND⁩ ⁦andrew seaton⁩ ⁦BSAC⁩ & many more - onto the next step! academic.oup.com/jacamr/article…

Last minute participation in #NationalHatDay All the credit goes to my learner for her quick idea on making paper hats